PERNIX THERAPEUTICS HLDGS IN's ticker is PTX and the CUSIP is 71426V108. A total of 99 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q4 2014. The put-call ratio across all filers is 3.13 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $82,000 | -3.5% | 78,456 | +173.0% | 0.00% | – |
| Q4 2015 | $85,000 | -4.5% | 28,740 | +2.5% | 0.00% | – |
| Q3 2015 | $89,000 | -36.9% | 28,040 | +17.7% | 0.00% | – |
| Q2 2015 | $141,000 | -66.5% | 23,832 | -39.4% | 0.00% | -100.0% |
| Q1 2015 | $421,000 | +82.3% | 39,352 | +59.9% | 0.00% | – |
| Q4 2014 | $231,000 | +16.1% | 24,611 | -4.9% | 0.00% | – |
| Q3 2014 | $199,000 | -25.5% | 25,885 | -13.0% | 0.00% | -100.0% |
| Q2 2014 | $267,000 | +86.7% | 29,740 | +11.1% | 0.00% | – |
| Q1 2014 | $143,000 | – | 26,780 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 2,484,649 | $7,330,000 | 8.59% |
| Avoro Capital Advisors LLC | 5,144,916 | $15,178,000 | 5.23% |
| Broadfin Capital, LLC | 6,090,829 | $17,968,000 | 1.10% |
| Aisling Capital LLC | 2,010,000 | $5,930,000 | 1.02% |
| Healthcare Value Capital, LLC | 150,000 | $443,000 | 0.73% |
| ACUTA CAPITAL PARTNERS, LLC | 434,300 | $1,281,000 | 0.61% |
| WALL STREET ASSOCIATES | 696,300 | $2,054,000 | 0.58% |
| SEARLE & CO. | 172,500 | $500,000 | 0.48% |
| Elk Creek Partners, LLC | 2,253,667 | $6,648,000 | 0.47% |
| KOPP INVESTMENT ADVISORS LLC | 315,293 | $931,000 | 0.46% |